By Elisabeth Mack
December 18th will be remembered as a historic turning point in American healthcare. On that day, President Donald J. Trump formally initiated the process to remove cannabis from Schedule I of the Controlled Substances Act, while also calling on Congress to modernize federal policy around hemp-derived cannabinoid products, including full-spectrum CBD.
The Background: Why Rescheduling Matters
For more than 55 years, cannabis has been classified as a Schedule I substance—defined as having no accepted medical use. This classification severely restricted research, limited medical guidance, and fueled stigma.
The current move toward Schedule III recognizes what clinicians, patients, and researchers have long known for centuries. Cannabis has accepted medical uses for people. It carries a lower abuse potential than Schedule I substances and it deserves a science-based regulatory framework
These actions support a more rational cannabinoid healthcare model—one that expands research access, improves patient care, and strengthens regulated, ethical pathways for treatment and innovation.
For patients, it brings validation and legitimacy. For clinicians, it fosters meaningful, informed dialogue. And for nurses, it reinforces what we’ve always practiced: compassionate, evidence-based care.
The recent decision to reschedule cannabis affirms what nurses have long known and advocated for: nursing belongs at the very center of cannabinoid care, not relegated to its margins. For years, nurses have been at the forefront, guiding patients through the complexities of cannabinoid medicine, and this policy change finally acknowledges their crucial role in providing safe and effective care. This moment validates the foresight, courage, and leadership of nurses everywhere.
The Impact on Nurses: A Defining Moment for the Profession
Nurses are healers, educators, advocates—and the most trusted profession in America. Many nurses have already been supporting patients with cannabinoid care, often without formal recognition or institutional backing. That is now changing. In 2023, the American Nurses Association formally adopted the Scope & Standards of Cannabis Nursing, establishing cannabis nursing as a recognized specialty practice—with board certification on the horizon.
Across oncology, palliative care, chronic pain, mental health, and aging populations, nurses have supported patients using cannabinoids for symptom relief and quality-of-life support. Often, this care occurred quietly—under stigma, regulatory ambiguity, and professional risk. Schedule I policy created a deep disconnect between clinical reality and federal law.
The Impact on Patients: Normalizing Cannabinoid Medicines
For patients, access to state-licensed medical cannabis dispensaries will continue as before. What changes with Schedule III is what becomes possible inside the traditional healthcare system.
This change could pave the way for FDA-approved cannabis medications to be prescribed by doctors and potentially covered by health insurance, integrating cannabis into mainstream medicine.
Holistic Caring & The Green Nurse anticipates:
- New prescription cannabinoid formulations
- Pharmacy-based distribution models
- Eventual payer and insurer participation
- Greater physician education on the endocannabinoid system
As stigma fades, conversations expand—opening pathways to healing that may reduce over-reliance on pharmaceuticals, especially for chronic and inflammatory conditions. This is holistic care moving into the mainstream. The Executive Order directs agencies including Department of Health and Human Services, Food and Drug Administration, Centers for Medicare & Medicaid Services, and National Institutes of Health to:
- Expand cannabis and CBD research and development
- Use real-world evidence to study long-term outcomes
- Focus on vulnerable populations such as youth and older adults
- Reduce research barriers created by Schedule I restrictions
Importantly, this action does not legalize cannabis federally, nor does it override state law. It does, however, lay the foundation for regulated, evidence-driven integration into healthcare.
For more information read Ask The Green Nurse Substack on Rescheduling
